Category Medical Specialty
CCC Critical Care compendium 340

Clenbuterol toxicity

Reviewed and revised 24 May 2014 OVERVIEW MECHANISM OF ACTION TOXICOKINETICS RISK ASSESSMENT CLINICAL FEATURES Effects include: Complications INVESTIGATIONS (Guided by clinical assessment) Laboratory tests MANAGEMENT Resuscitation Supportive care and monitoring Decontamination Disposition References and Links Journal articles

CCC Critical Care compendium 340

High-dose Insulin Euglycaemic Therapy

High-dose Insulin Euglycaemic Therapy (HIET) is primarily used in the therapy of severe calcium channel blocker toxicity. HIET can also be used for severe beta blocker toxicity and potentially other toxicities/ presentations requiring inotropic support

CCC Critical Care compendium 340

Amphetamine Toxicity

Sympathomimetic syndrome with potential for life-threatening vascular complications (ischemia, dissection and haemorrhage). Note: ecstasy is also associated with hyponatraemia

CCC Critical Care compendium 340

Fluid Responsiveness

Fluid responsiveness is an increase of stroke volume of 10-15% after the patient receives 500 ml of crystalloid over 10-15 minutes (as defined by Paul Marik). The definitive test for fluid responsiveness is a Fluid challenge

CCC Critical Care compendium 340

Haemoperfusion

Haemoperfusion: Renal replacement therapy (RRT) using an adsorbent cartridge to remove circulating toxins

CCC Critical Care compendium 340

Extracorporeal Elimination in Toxicology

Extracorporeal Elimination recommended for the following intoxications: methotrexate, procanamide, lithium, metformin, ethanol, methanol, ethylene glycol, salicylates, theophylline, sodium valproate.

Ultrasound cases top 100 340

Ultrasound Case 069

A 26 year old woman describes sudden severe left iliac fossa pain late in the evening prior to presentation. On the morning of presentation she complained of bilateral shoulder tip pain and had a presyncopal episode on standing up. She is not pregnant.